Source: Annual Congress 2009 - Drug effects in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Makita, S. Konno, M. Hasegawa, K. Shimizu, Y. Nasuhara, T. Betsuyaku, M. Nishimura, Hokkaido COPD Cohort Study Group (Sapporo, Japan). Association of β2-adrenoreceptor genotype with bronchodilator responses (bdr) in COPD. Eur Respir J 2009; 34: Suppl. 53, 1998

Member's Comments

No comment yet.

Related content which might interest you: Association of β2-adrenoceptor genotypes with bronchodilatory effect of tiotropium in COPD Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Association between genetic polymorphisms of the β2-AR and response to salbutamol in patients with atopic bronchial asthma of Kyrgyz nationality Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006 Association of TNF-α polymorphisms with COPD in a Spanish population Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Association between the GLCCI1 variant and response to inhaled corticosteroids in South Vietnamese asthmatics Source: International Congress 2018 – Variant forms of asthma Year: 2018 Respiratory health and endotoxin: associations and modification by CD14/-260 genotype Source: Eur Respir J 2012; 39: 573-581 Year: 2012 Association between genetic polymorphisms of ADAM33 with asthma and its phenotypes Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 VNTR polymorphism in IL1RN gene in COPD and bronchial astma in Bulgarian population Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Haplotypes associated with COPD and its severity in Mexican mestizo population Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Algorithm for identification of asthma–COPD overlap: consensus between the Spanish COPD and asthma guidelines Source: Eur Respir J, 49 (5) 1700068; 10.1183/13993003.00068-2017 Year: 2017 Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Efficacy and tolerability of budesonide/formoterol (B/F) added to tiotropium (T) vs T alone in East-Asian patients (pts) with severe/very severe chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Association between ADAM33 polymorphisms and asthma control Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013